Skip to content

GE HealthCare Technologies GEHC PCS — Acquisitions

Other segment segments

Imaging
$1.58B
AVS
$0
PDx
$0-100%

Similar metrics at other companies

HP logo
HPQPersonal Systems — Acquisitions
$0-100%
Ryder System logo
RSCS — Acquisitions
$250K-94.4%
Flex Ltd. logo
FLEXCPI — Acquisitions
$2M-96.0%
Ryder System logo
RSCS — Payments to Acquire Productive Assets
$30M+11.1%
Fortive logo
FTVIntelligent Operating Solutions — Payments to Acquire Productive Assets
$20.7M+22.5%
Service Corporation International logo
SCICorporate Segment and Other Operating Segment — Payments to Acquire Productive Assets
$711.75K-63.2%

Other financials

Income statement

See full
Revenue$5.1B+7.4%
Gross profit$2.0B-1.7%
Operating income$515.0M-18.1%
Net income$389.0M-31.0%
EPS (diluted)$0.85-30.9%

Balance sheet

See full
Total debt$10.6B+15.2%
Total equity$10.7B+16.1%
Total assets$37.1B+10.5%

Cash flow

See full
Operating cash flow$290.0M+16.0%
CapEx$178.0M+17.1%
Free cash flow$112.0M+14.3%

Valuation

See full
Market cap$29.91B-9.2%
P/E15.7×+1.0×
P/S1.4×-0.2×

Profitability

See full
Gross margin39.1%-2.9pp
Operating margin12.6%-1.1pp
Net margin9.1%-1.9pp
FCF margin7.2%

Returns & leverage

See full
Return on equity19.2%-7.1pp
Debt / equity0.0×
Current ratio1.2×+0.2×

Where this comes from

Reported directly by GE HealthCare Technologies in its filing.

Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.

The official record: GE HealthCare Technologies’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about GE HealthCare Technologies's pcs — acquisitions.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is GE HealthCare Technologies's PCS — acquisitions?
GE HealthCare Technologies (GEHC) reported PCS — acquisitions of $0 in Q1 2026.
What does PCS — acquisitions mean?
The capital expenditure or cash outflow specifically directed toward the purchase of other businesses or technologies to be integrated into the Patient Care Solutions segment. This highlights the segment's inorganic growth strategy and R&D pipeline expansion.